ZB
Zenas BioPharma
ZBIO·NASDAQWaltham MAFounded 2018100 employees
Small CapbiotechPublicImmunologyRare Disease
Platform: Obexelimab FcRn
Market Cap
$1.5B
All Drugs
2
Clinical Trials
4
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (ZBIO)
Loading ZBIO stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Taladerotide | ZBI-4137 | Phase 2/3 | 2 | SHP2 | CF | ||
| Lirainavolisib | ZBI-5761 | Preclinical | 2 | TIGIT | FTDPsoriasis |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (3)